Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 10 June 2027
- Last conf. stmt
- 27 May 2026
Evinova Limited
- Incorporated
- 16 February 2024 (2 years)
- Industry
- Information technology consultancy activities (62020)
- Directors
- Gillian Anderson BowdenDawn Louise Plowman
- Owned by
- Accounts type
- Full
- Region
- East of England
- Address
- 1 Francis Crick AvenueCambridge Biomedical CampusCambridgeCB2 0AA
Officers 2 active
Officer details are public data from the Companies House register.
Bowden, Gillian Anderson
Director · Appointed 31 July 2026
British
Born December 1975 (50)
Plowman, Dawn Louise
Director · Appointed 31 July 2026
British
Born September 1979 (47)
Officer history (4 former)
31 July 2026
Appointed Bowden, Gillian Anderson as Director
31 July 2026
Appointed Plowman, Dawn Louise as Director
31 July 2026
Resigned Bonam, Matthew James as Director
31 July 2026
Resigned Mcarthur, Adam as Director
19 February 2024
Appointed Bonam, Matthew James as Director
19 February 2024
Appointed Mcarthur, Adam as Director
19 February 2024
19 February 2024
16 February 2024
16 February 2024
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 16 February 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 3674842
Former controllers (1)
16 February 2024
Ceased Evinova AG — Owns 75–100% of shares
Group structure 19 shown
Ownership group derived from the Companies House PSC register
Astrazeneca Intermediate Holdings Limited Owns 75–100% of shares
Astrazeneca UK Limited Owns 75–100% of shares
Alderley Park Ventures Limited Has significant influence or control
Astrazeneca Death in Service Trustee Limited Owns 75–100% of shares
Astrazeneca Employee Share Trust Limited Owns 75–100% of shares
Astrazeneca Nominees Limited Owns 75–100% of shares
Astrazeneca Quest Limited Owns 75–100% of shares
Astrazeneca Share Trust Limited Owns 75–100% of shares
Astrazeneca Treasury Limited Owns 75–100% of shares
British Pharma Group Limited Holds 25–50% of voting rights
Evinova Limited This company Owns 75–100% of shares
Kudos Pharmaceuticals Limited Owns 75–100% of shares
Medimmune U.K. Limited Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 August 2026 | Appointment of a director | 2 | ||
| 5 August 2026 | Termination of appointment of a director | 1 | ||
| 5 August 2026 | Termination of appointment of a director | 1 | ||
| 4 August 2026 | Appointment of a director | 2 | ||
| 29 May 2026 | Confirmation statement with updates | 27 May 2026 | 3 |
Some other companies at this address
Other companies in this industry
Aberdeen
Edinburgh
Glasgow
Bracknell
Warrington
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →